Maravai LifeSciences
在场
高管
查看带有其 18 名主要高管的组织结构图
Maravai LifeSciences 搜索最多的简介
- William Martin, Chief Executive Officer and Director
- Carl Hull, Chairman of the Board
- Murali Prahalad, Director
高管在Maravai LifeSciences变化
- Anat Ashkenazi, Director, 将于 20247月30 退休 (新闻发布的2024六月13号).
创建提醒
跟踪 Maravai LifeSciences 的高管变动
生物技术
Maravai LifeSciences 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Maravai LifeSciences 的最新新闻稿
- Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
- TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
- Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
- Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
- Press Releases
- Maravai LifeSciences Reports Second Quarter 2024 Financial Results
- Maravai LifeSciences Appoints Trey Martin to Board of Directors
- Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
- Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
- Maravai LifeSciences Reports First Quarter 2024 Financial Results
- View more press releases Close
通过电子邮件
